Pelvic exenterative procedures for locally advanced or recurrent colorectal carcinoma in a community hospital

Vitelli, C.E.; Crenca, F.; Fortunato, Lucio; Nardo, Anna Di; Farina, Miriam; Mustacciuoli, G.

doi:10.1007/s10151-003-0028-2

Cited by 8 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This feature is seen in approx. 10% of the cancers that start in the pelvic region, being refered to as locally advanced pelvic cancer (1)(2)(3)(4)(5)(6)(7)(8). Locally advanced pelvic cancer include pelvic particular forms of cancer, with a marked local aggressiveness, in the sense of a massive invasion locally, but at the same time, in the absence of distance dissemination, the pelvic region being (clear or apparent) the only location of the neoplasia.…”

Section: Introduction Introductionmentioning

confidence: 99%

Radical surgical treatement in pelvic advanced cancer

Mitulescu¹,

Gluck²,

Stingu³

2011

Annals of Fundeni Hospital

View full text Add to dashboard Cite

Total pelvic exenteration (TPE) is a radical and aggressive procedure performed in the local advanced pelvic cancer started from any pelvic organ. The experience of 213 TPE performed for local invasive cancer and centro-pelvic recurrences with initial malignancy at the cervix (125 cases), rectum (48 cases), vagina (11 cases), endometer (11 cases), ovary (9 cases), urinary bladder (3 cases), vulva (2 cases), retroperitoneum (2 cases), prostate (1 case) and myometrium (1 case), in 173 females and 40 males with age range 21-78 years, are analysed. The procedures were performed for advanced pelvic cancer in 71 cases (33.34%) and also for invasive centro-pelvic recurrences in 142 cases (66.66%). In 78 cases, TPE was extended laterally. 24 were composite resections. In 125 patients reconstructive procedures were added. All patients survived to surgery but 17 postoperative deaths (7.98%) were recorded. Complications occurred in 45.53% of cases, 97 from 213 patients had one or more than one complication with an average of 1.5 per patient. 52 among these patients (24.41%) requiring operative treatment. The average survival was 49.07 months, the median survival of 55 months and the estimated survival at 11 and 78 months was 66%, respectively 50%. The procedure is indicated in the absence of pelvic wall invasion and secondary distant dissemination and lengthens significantly the life span and increase the quality of life.

show abstract